title: Central lipoprivation-induced suppression of luteinizing hormone pulses is mediated by paraventricular catecholaminergic inputs in female rats.
abstract: The present study aims to clarify the role of fatty acids in regulating pulsatile LH secretion in rats. To produce an acute central lipoprivic condition, mercaptoacetate (MA), an inhibitor of fatty acids oxidation, was administered into the fourth cerebroventricle (4V) in ad libitum fed ovariectomized (OVX) rats (0.4, 2, and 10 micromol/rat) with or without an estradiol (E2) implant producing diestrus plasma E2 levels. Pulsatile LH secretion was suppressed by 4V MA administration in a dose-dependent manner in both OVX and OVX plus E2 rats. Mean LH levels and LH pulse frequency and amplitude were significantly reduced by the highest dose of MA in OVX rats, and by the middle and highest dose of MA in E2-treated rats, suggesting that estrogen enhanced LH suppression. Blood glucose levels increased immediately after the highest dose of MA in both groups. Fourth ventricular injection of trimetazidine (2 and 3 micromol/rat), another inhibitor of fatty acids oxidation, also inhibited pulsatile LH release, resulting in significant and dose-dependent suppression of LH pulse frequency and an increase in blood glucose levels in OVX plus E2 rats. In contrast, peripheral injection of the highest 4V dose of MA (10 micromol/rat) did not alter LH release or blood glucose levels. Microdialysis of the hypothalamic paraventricular nucleus (PVN) revealed that norepinephrine release in the region was increased by 4V MA administration. Preinjection of alpha-methyl-p-tyrosine, a catecholamine synthesis inhibitor, into the PVN completely blocked the lipoprivic inhibition of LH and the counter-regulatory increase in blood glucose levels in OVX plus E2 rats. Together, these studies indicate that fatty acid availability may be sensed by a central detector, located in the lower brainstem to maintain reproduction, and that noradrenergic inputs to the PVN mediate this lipoprivic-induced suppression of LH release.
authors.affiliation: Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.
authors.forename: Somchai
authors.initials: S
authors.lastname: Sajapitak
authors.forename: Kinuyo
authors.initials: K
authors.lastname: Iwata
authors.forename: Mohammad
authors.initials: M
authors.lastname: Shahab
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Uenoyama
authors.forename: Shunji
authors.initials: S
authors.lastname: Yamada
authors.forename: Mika
authors.initials: M
authors.lastname: Kinoshita
authors.forename: Farida Y
authors.initials: FY
authors.lastname: Bari
authors.forename: Helen
authors.initials: H
authors.lastname: I'Anson
authors.forename: Hiroko
authors.initials: H
authors.lastname: Tsukamura
authors.forename: Kei-ichiro
authors.initials: K
authors.lastname: Maeda
mesh_terms: D000818:Animals; D002395:Catecholamines / Q000096:biosynthesis / Q000502:physiology*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008055:Lipids / Q000172:deficiency / Q000502:physiology*; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010052:Ovariectomy; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D013864:Thioglycolates / Q000494:pharmacology; D014292:Trimetazidine / Q000494:pharmacology
chemical_list: D002395:Catecholamines; D008055:Lipids; D013864:Thioglycolates; D004958:Estradiol; C017487:2-mercaptoacetate; D007986:Luteinizing Hormone; D014292:Trimetazidine